AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value

$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie total Net Revenues — International ($M) ($M)

Form 8-K Key Product Revenues

Quarterly Annual

Latest, FY2025

14,557

Period ended Dec 31, 2025

Change on a year earlier

+9.4%

13,305 in FY2024

History

4 years

Since FY2022

Sources

Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Total Net Revenues — International ($M) ($M)	Year on year	Source
FY2025	Dec 31, 2025	14,557	+9.4%	Form 8-K (abbv-20251231xexhibit991.htm, filed 2026-02-04) ↗
FY2024	Dec 31, 2024	13,305	+7.0%	Form 8-K (abbv-20241231xexhibit991.htm, filed 2025-01-31) ↗
FY2023	Dec 31, 2023	12,435	+0.8%	Form 8-K (abbv-20231231xexhibit991.htm, filed 2024-02-02) ↗
FY2022	Dec 31, 2022	12,341	–	Form 8-K (abbv-20221231xexhibit991.htm, filed 2023-02-09) ↗

Breakdown

What makes up total net revenues — international ($m)

Cite this data

StockData. (2026). AbbVie Total Net Revenues — International ($M) ($M), annual FY2022–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/rev_total_intl

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.